Literature DB >> 12069824

Lysophospholipid mediators of immunity and neoplasia.

Mei Chuan Huang1, Markus Graeler, Geetha Shankar, Juliet Spencer, Edward J Goetzl.   

Abstract

Lysophosphatidic acid (LPA), sphingosine 1-phosphate (S1P) and some other structurally related lysophospholipids are active growth factors and stimuli for diverse cellular functions. LPA and S1P promote early T cell migration to tissue sites of immune responses and regulate T cell proliferation and secretion of numerous cytokines. Edg-4 (LPA2) LPA receptors, which are constitutively expressed by helper T cells, and Edg-2 (LPA1) LPA receptors, which are expressed only by activated helper T cells, transduce opposite effects of LPA on some T cell responses. A similar mechanism is observed for fine regulation of Edg R-mediated effects of LPA on ovarian cancer cells. Edg-4 (LPA2) R transduces proliferative responses, recruitment of autocrine protein growth factors, and migration of ovarian cancer cells, whereas Edg-2 (LPA1) R transduces inhibition of Edg-4 (LPA2) R-mediated responses and concurrently elicits apoptosis and anoikis of ovarian cancer cells. Edg-4 (LPA2) R is a distinctive functional marker for ovarian carcinoma, and is expressed both as the wild-type and a carboxyl-terminally extended gain-of-function mutant. Newly discovered non-lipid agonists and antagonists for individual Edg receptors will permit more sophisticated analyses of their respective contributions in human biology and pathophysiology, and may represent novel therapeutic modalities in immune disorders and cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069824     DOI: 10.1016/s1388-1981(02)00151-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 2.  A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).

Authors:  Jerold Chun; Volker Brinkmann
Journal:  Discov Med       Date:  2011-09       Impact factor: 2.970

3.  Lysophospholipids and their G protein-coupled receptors in atherosclerosis.

Authors:  Ya-Feng Li; Rong-Shan Li; Sonia B Samuel; Ramon Cueto; Xin-Yuan Li; Hong Wang; Xiao-Feng Yang
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01-01

4.  Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells.

Authors:  Yutong Zhao; Peter V Usatyuk; Rhett Cummings; Bahman Saatian; Donghong He; Tonya Watkins; Andrew Morris; Ernst W M Spannhake; David N Brindley; Viswanathan Natarajan
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

5.  The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer.

Authors:  Songbai Lin; Dongsheng Wang; Smita Iyer; Amr M Ghaleb; Hyunsuk Shim; Vincent W Yang; Jerold Chun; C Chris Yun
Journal:  Gastroenterology       Date:  2009-01-09       Impact factor: 22.682

6.  LysoPtdOH enhances CXCL16 production stimulated by LPS from macrophages and regulates T cell migration.

Authors:  Shijun Kang; Chunlan Yang; Rongcheng Luo
Journal:  Lipids       Date:  2008-10-02       Impact factor: 1.880

Review 7.  Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.

Authors:  Gabor J Tigyi; Junming Yue; Derek D Norman; Erzsebet Szabo; Andrea Balogh; Louisa Balazs; Guannan Zhao; Sue Chin Lee
Journal:  Adv Biol Regul       Date:  2018-09-16

8.  Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.

Authors:  Shinji Sakamoto; Masahiro Yokoyama; Xianghua Zhang; Kulkarni Prakash; Kaori Nagao; Takashi Hatanaka; Robert H Getzenberg; Yoshiyuki Kakehi
Journal:  Endocrinology       Date:  2004-02-26       Impact factor: 4.736

9.  Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma.

Authors:  Joji Kitayama; Dai Shida; Akihiro Sako; Makoto Ishikawa; Kotaro Hama; Junken Aoki; Hiroyuki Arai; Hirokazu Nagawa
Journal:  Breast Cancer Res       Date:  2004-09-22       Impact factor: 6.466

10.  Increased levels of sphingosine-1-phosphate in cerebrospinal fluid of patients diagnosed with tick-borne encephalitis.

Authors:  Alina Kułakowska; Fitzroy J Byfield; Małgorzata Zendzian-Piotrowska; Joanna M Zajkowska; Wiesław Drozdowski; Barbara Mroczko; Paul A Janmey; Robert Bucki
Journal:  J Neuroinflammation       Date:  2014-11-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.